BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11907818)

  • 1. Dofetilide block involves interactions with open and inactivated states of HERG channels.
    Weerapura M; Hébert TE; Nattel S
    Pflugers Arch; 2002 Feb; 443(4):520-31. PubMed ID: 11907818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular determinants of dofetilide block of HERG K+ channels.
    Ficker E; Jarolimek W; Kiehn J; Baumann A; Brown AM
    Circ Res; 1998 Feb; 82(3):386-95. PubMed ID: 9486667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular physiology and pharmacology of HERG. Single-channel currents and block by dofetilide.
    Kiehn J; Lacerda AE; Wible B; Brown AM
    Circulation; 1996 Nov; 94(10):2572-9. PubMed ID: 8921803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acidification alters antiarrhythmic drug blockade of the ether-a-go-go-related Gene (HERG) Channels.
    Dong DL; Li Z; Wang HZ; Du ZM; Song WH; Yang BF
    Basic Clin Pharmacol Toxicol; 2004 May; 94(5):209-12. PubMed ID: 15125690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation gating determines drug potency: a common mechanism for drug blockade of HERG channels.
    Yang BF; Xu DH; Xu CQ; Li Z; Du ZM; Wang HZ; Dong DL
    Acta Pharmacol Sin; 2004 May; 25(5):554-60. PubMed ID: 15132818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular determinants of inactivation and dofetilide block in ether a-go-go (EAG) channels and EAG-related K(+) channels.
    Ficker E; Jarolimek W; Brown AM
    Mol Pharmacol; 2001 Dec; 60(6):1343-8. PubMed ID: 11723241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High affinity open channel block by dofetilide of HERG expressed in a human cell line.
    Snyders DJ; Chaudhary A
    Mol Pharmacol; 1996 Jun; 49(6):949-55. PubMed ID: 8649354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing the interaction between inactivation gating and Dd-sotalol block of HERG.
    Numaguchi H; Mullins FM; Johnson JP; Johns DC; Po SS; Yang IC; Tomaselli GF; Balser JR
    Circ Res; 2000 Nov; 87(11):1012-8. PubMed ID: 11090546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential recovery of action potential duration and HERG currents from the effects of two methanesulfonamide class III antiarrhythmic agents, KCB-328 and dofetilide.
    Lee K; Park JB; Jeon BH; Kim KJ; Ryu PD; Kwon LS; Kim HY
    J Cardiovasc Pharmacol; 2003 Nov; 42(5):648-55. PubMed ID: 14576514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of currents carried by HERG, with and without coexpression of MiRP1, and the native rapid delayed rectifier current. Is MiRP1 the missing link?
    Weerapura M; Nattel S; Chartier D; Caballero R; Hébert TE
    J Physiol; 2002 Apr; 540(Pt 1):15-27. PubMed ID: 11927665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open channel block by KCB-328 [1-(2-amino-4-methanesulfonamidophenoxy)-2-[N-(3,4-dimethoxyphenethyl)-N-methylamino]ethane hydrochloride] of the heterologously expressed human ether-a-go-go-related gene K+ channels.
    Park JB; Choe H; Lee YK; Ha KC; Rhee KS; Ko JK; Joo CU; Chae SW; Kwak YG
    J Pharmacol Exp Ther; 2002 Jul; 302(1):314-9. PubMed ID: 12065732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Class III antiarrhythmic drugs block HERG, a human cardiac delayed rectifier K+ channel. Open-channel block by methanesulfonanilides.
    Spector PS; Curran ME; Keating MT; Sanguinetti MC
    Circ Res; 1996 Mar; 78(3):499-503. PubMed ID: 8593709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of block and identification of the verapamil binding domain to HERG potassium channels.
    Zhang S; Zhou Z; Gong Q; Makielski JC; January CT
    Circ Res; 1999 May; 84(9):989-98. PubMed ID: 10325236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single HERG delayed rectifier K+ channels expressed in Xenopus oocytes.
    Zou A; Curran ME; Keating MT; Sanguinetti MC
    Am J Physiol; 1997 Mar; 272(3 Pt 2):H1309-14. PubMed ID: 9087606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase A-mediated phosphorylation of HERG potassium channels in a human cell line.
    Wei Z; Thomas D; Karle CA; Kathöfer S; Schenkel J; Kreye VA; Ficker E; Wible BA; Kiehn J
    Chin Med J (Engl); 2002 May; 115(5):668-76. PubMed ID: 12133532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of HERG potassium channel current by the class 1a antiarrhythmic agent disopyramide.
    Paul AA; Witchel HJ; Hancox JC
    Biochem Biophys Res Commun; 2001 Feb; 280(5):1243-50. PubMed ID: 11162661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation of E-4031 from the HERG channel caused by mutations of an amino acid results in greater block at high stimulation frequency.
    Ishii K; Nagai M; Takahashi M; Endoh M
    Cardiovasc Res; 2003 Mar; 57(3):651-9. PubMed ID: 12618227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes.
    Suessbrich H; Schönherr R; Heinemann SH; Attali B; Lang F; Busch AE
    Br J Pharmacol; 1997 Mar; 120(5):968-74. PubMed ID: 9138706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872.
    Thomas D; Wendt-Nordahl G; Röckl K; Ficker E; Brown AM; Kiehn J
    J Pharmacol Exp Ther; 2001 May; 297(2):753-61. PubMed ID: 11303067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the class III antiarrhythmic agent dofetilide (UK-68,798) on L-type calcium current from rabbit ventricular myocytes.
    Paul AA; Leishman DJ; Witchel HJ; Hancox JC
    J Pharm Pharmacol; 2001 Dec; 53(12):1671-8. PubMed ID: 11804397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.